TNF mRNA

TNF mRNA is a ready-to-use messenger RNA (mRNA) encoding tumor necrosis factor alpha (TNF-α), a pro-inflammatory cytokine that regulates acute and chronic inflammation, autoimmune diseases, and tumor-associated inflammation, and can induce cell apoptosis and necrosis. It is suitable for research on inflammation, immune regulation, tumor immunotherapy, and mRNA delivery. The transcript is designed for expression in eukaryotic cells. It contains the nucleic acid sequence encoding the 176 amino acid TNF protein sequence, together with non-coding regulatory elements typically required for efficient translation and stability (5′ untranslated region, 3′ untranslated region, and a 3′ poly(A) tail). The mRNA contains a 5′ Cap 1 structure, and all uridine residues are fully substituted with N1-methyl-pseudouridine (m¹Ψ) to support robust protein expression and to reduce innate immune sensing relative to unmodified mRNA. The mRNA is produced enzymatically by in vitro transcription from a DNA template, followed by capping, polyadenylation, and purification. Promoter sequences used to drive in vitro transcription from the DNA template are not part of the final mRNA product. For research use only (RUO). Not for diagnostic or therapeutic use, and not for human or animal administration.